Correlation Between PTC Therapeutics and Sarepta Therapeutics
Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PTC Therapeutics and Sarepta Therapeutics, you can compare the effects of market volatilities on PTC Therapeutics and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and Sarepta Therapeutics.
Diversification Opportunities for PTC Therapeutics and Sarepta Therapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between PTC and Sarepta is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and Sarepta Therapeutics go up and down completely randomly.
Pair Corralation between PTC Therapeutics and Sarepta Therapeutics
Given the investment horizon of 90 days PTC Therapeutics is expected to generate 1.04 times more return on investment than Sarepta Therapeutics. However, PTC Therapeutics is 1.04 times more volatile than Sarepta Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 4,551 in PTC Therapeutics on October 20, 2024 and sell it today you would lose (167.00) from holding PTC Therapeutics or give up 3.67% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
PTC Therapeutics vs. Sarepta Therapeutics
Performance |
Timeline |
PTC Therapeutics |
Sarepta Therapeutics |
PTC Therapeutics and Sarepta Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PTC Therapeutics and Sarepta Therapeutics
The main advantage of trading using opposite PTC Therapeutics and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.PTC Therapeutics vs. Krystal Biotech | PTC Therapeutics vs. Sarepta Therapeutics | PTC Therapeutics vs. Iovance Biotherapeutics | PTC Therapeutics vs. Madrigal Pharmaceuticals |
Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |